High levels of tumor endothelial marker-7 (TEM-7), vascular endothelial-cadherin and CD31 encouraged NF-κB-dependent AKT activation and VEGF expression in tumor-associated endothelial cells (TAECs), thereby inducing gemcitabine resistance in HCC [92]. The gene discussed is AKT1; the disease is neoplasm.